| Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. | |
| | |
MedLine Citation:
|
PMID: 20360279 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Acamprosate, oral and long-acting injectable naltrexone, and disulfiram are approved for treatment of alcohol dependence. Their availability and consideration of their use in treatment are now standards of high-quality care. This study determined rates of medication initiation among Veterans Health Administration (VHA) patients. METHODS: VHA pharmacy and administrative data were used to identify patients with alcohol use disorder diagnoses in fiscal years (FY) 2006 and 2007 and the proportion (nationally and by facility) who received each medication. Patient characteristics associated with receipt were also examined. RESULTS: Among more than a quarter-million patients with alcohol use disorder diagnoses, the percentage receiving any of the medications increased from 2.8% in FY 2006 to 3.0% in FY 2007. Receipt of these medications was more likely among patients who received specialty addiction care, those with alcohol dependence (compared with abuse), those younger than 55 years, and females. In the patient subgroups examined, the largest proportion to receive any of the medications was 11.6%. Across 128 VHA facilities, rates of use among patients in the sample who had received past-year specialty addiction treatment ranged from 0% to 20.5%; rates ranged from 0% to 4.3% among those with no specialty treatment. Patient preferences and medical contraindications could not be determined from the data. CONCLUSIONS: Findings suggest the need to better understand systemwide variation in use of these medications and their use as a rough proxy for availability and consideration of pharmacotherapy--a standard of care with strong organizational support. |
| | |
Authors:
|
Alex H S Harris; Daniel R Kivlahan; Thomas Bowe; Keith N Humphreys |
Related Documents
:
|
727889 - Multiple predictors of dropout from alcoholism treatment. 739379 - Clinical correlates of the prf androgyny scale in an alcoholic population. 11093959 - Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. 21907499 - Why medication in involuntary treatment may be less effective: the placebo/nocebo effect. 19655099 - The use of disulfiram for alcohol-dependent patients and duration of outpatient treatment. 8096109 - Use of ultrasound in a study of schistosomal periportal fibrosis in rural zimbabwe. 21658289 - A system for de-identifying medical message board text. 18791299 - Atlantic conjunctures in anglo-american neurology: lewis h. weed and johns hopkins neur... 1887839 - Creativity in medical genetics and dysmorphology. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. |
Journal Detail:
|
Title: Psychiatric services (Washington, D.C.) Volume: 61 ISSN: 1557-9700 ISO Abbreviation: Psychiatr Serv Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-04-02 Completed Date: 2010-06-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9502838 Medline TA: Psychiatr Serv Country: United States |
Other Details:
|
Languages: eng Pagination: 392-8 Citation Subset: IM |
Affiliation:
|
Center for Health Care Evaluation, Department of Veterans Affairs Palo Alto Health Care System, 795 Willow Rd. (MC152), Menlo Park, CA 94025, USA. alexander.harris2@va.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Adult Age Factors Alcohol Deterrents / therapeutic use* Alcoholism / epidemiology, rehabilitation* Ambulatory Care Comorbidity Delayed-Action Preparations Disulfiram / therapeutic use* Drug Therapy, Combination Drug Utilization / statistics & numerical data Female Humans Injections, Intramuscular Male Mental Disorders / epidemiology, rehabilitation Middle Aged Naltrexone / therapeutic use* Serotonin Uptake Inhibitors / therapeutic use Sex Factors Substance Abuse Treatment Centers / statistics & numerical data Taurine / analogs & derivatives*, therapeutic use United States Veterans / psychology*, statistics & numerical data |
| Chemical | |
Reg. No./Substance:
|
0/Alcohol Deterrents; 0/Delayed-Action Preparations; 0/Serotonin Uptake Inhibitors; 107-35-7/Taurine; 16590-41-3/Naltrexone; 77337-76-9/acamprosate; 97-77-8/Disulfiram |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pregnancy-related discontinuation of antidepressants and depression care visits among medicaid recip...
Next Document: Consequences of receipt of a psychiatric diagnosis for completion of college.